ConductScience.org, home

Paper21397858

Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.

Sawey ET and 13 others. Cancer Cell, 2011. Cited by 375 papers, by iCite.

Cite this record

ConductScience Library. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Papers, record 21397858. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21397858

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.
PubMed
Journal
Cancer Cell
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
375
iCite
Relative citation ratio, by iCite
8.36
iCite
Revised in PubMed
2025-05-29
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sawey ETEric T
2Chanrion MMaia
3Cai CChunlin
4Wu GGuanming
5Zhang JJianping
6Zender LLars
7Zhao AAlice
8Busuttil RWRonald W
9Yee HHerman
10Stein LLincoln
11French DMDorothy M
12Finn RSRichard S
13Lowe SWScott W
14Powers SScott

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Fibroblast Growth FactorsMajor topic
Liver NeoplasmsMajor topic
Oncogene ProteinsMajor topic
Animals
Antibodies, Monoclonal
Cell Line, Tumor
Cell Proliferation
Chromosomes, Human, Pair 11
Cyclin D1
Female
Gene Amplification
Gene Expression Regulation, Neoplastic
Genetic Predisposition to Disease
Genomics
Humans
Immunoblotting
Mice
Mice, Nude
RNA Interference
Tumor Burden
Xenograft Model Antitumor Assays

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA076905NCI NIH HHSUnited StatesK12CA076905PubMed and NIHNIH RePORTER
R01 CA124648NCI NIH HHSUnited StatesR01CA124648PubMed and NIHNIH RePORTER
RC2 CA148532NCI NIH HHSUnited StatesRC2CA148532PubMed and NIHNIH RePORTER
CA148532NCI NIH HHSUnited StatesRC2CA148532PubMed and NIHNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed and NIHNIH RePORTER
U01 CA105388NCI NIH HHSUnited StatesU01CA105388PubMed and NIHNIH RePORTER
P01 CA013106NCI NIH HHSUnited StatesP01CA013106PubMed and NIHNIH RePORTER
CA105388NCI NIH HHSUnited StatesU01CA105388PubMed and NIHNIH RePORTER
CA124648NCI NIH HHSUnited StatesR01CA124648PubMed and NIHNIH RePORTER
K12 CA076905NCI NIH HHSUnited StatesK12CA076905PubMed and NIHNIH RePORTER

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119366792Identification of potential driver genes in human liver carcinoma by genomewide screening.Cancer Res2009https://conductscience.org/library/papers/19366792PubMed
220018895FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.J Biol Chem2010https://conductscience.org/library/papers/20018895PubMed
318980784RNA polymerases I and III, non-coding RNAs and cancer.Trends Genet2008https://conductscience.org/library/papers/18980784PubMed
415946945Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine.J Biol Chem2005https://conductscience.org/library/papers/15946945PubMed
510984191Protective effect of supplemental superoxide dismutase on survival of neuronal cells during starvation. Requirement for cytosolic distribution.J Mol Neurosci2000https://conductscience.org/library/papers/10984191PubMed
611408803Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.Oncology2001https://conductscience.org/library/papers/11408803PubMed
712975311Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation.Genome Res2003https://conductscience.org/library/papers/12975311PubMed
817599042Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.Oncogene2008https://conductscience.org/library/papers/17599042PubMed
918593907Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.Cancer Res2008https://conductscience.org/library/papers/18593907PubMed
1018347015Roles of Pofut1 and O-fucose in mammalian Notch signaling.J Biol Chem2008https://conductscience.org/library/papers/18347015PubMed
1111454681Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.Cancer Res2001https://conductscience.org/library/papers/11454681PubMed
1217511024Genetics of hepatocellular carcinoma.World J Gastroenterol2007https://conductscience.org/library/papers/17511024PubMed
139552382A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry.Prog Cell Cycle Res1996https://conductscience.org/library/papers/9552382PubMed
1420160489Differences underlying EGFR and HER2 oncogene addiction.Cell Cycle2010https://conductscience.org/library/papers/20160489PubMed
1512057932A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.Am J Pathol2002https://conductscience.org/library/papers/12057932PubMed
1612676587Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene.Cancer Cell2003https://conductscience.org/library/papers/12676587PubMed
1718701503Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.Cancer Res2008https://conductscience.org/library/papers/18701503PubMed
1810066073HER-2/neu as a predictive marker of response to breast cancer therapy.Breast Cancer Res Treat1998https://conductscience.org/library/papers/10066073PubMed
1912923544Chromosome aberrations in solid tumors.Nat Genet2003https://conductscience.org/library/papers/12923544PubMed
2018451130Oncogene addiction.Cancer Res2008https://conductscience.org/library/papers/18451130PubMed

See all 48 referencesDownload CSV of references

Cited by229

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 375 citations.

PMIDTitleJournalYearIn PapersSource
42640574Phase 2 study of futibatinib in combination with pembrolizumab in patients with FGF19 expressing advanced hepatocellular carcinoma.Oncologist2026https://conductscience.org/library/papers/42640574PubMed
42491058The role of FGF19-FGFR4 signaling pathway in liver health and disease: Guardian or destroyer.Genes Dis2026https://conductscience.org/library/papers/42491058PubMed
41737892Lactylation-related genes signature panel in hepatocellular carcinoma reveals the prognostic and therapeutic optimization.Mol Cell Oncol2026https://conductscience.org/library/papers/41737892PubMed
41716515Targeted therapy for liver cancer: Current status and future directions.Bioimpacts2025https://conductscience.org/library/papers/41716515PubMed
41328353FGF19 in Solid Tumors: Molecular Mechanisms, Metabolic Reprogramming, and Emerging Therapeutic Opportunities.Theranostics2026https://conductscience.org/library/papers/41328353PubMed
41301037Transforming Liver Cancer Therapy: Integrating Molecular Profiling with Precision and Transplant-Based Care.Cancers (Basel)2025https://conductscience.org/library/papers/41301037PubMed
41097083Reactivation of the PI3K/mTOR Signaling Pathway Confers Resistance to the FGFR4 Inhibitor FGF401.Int J Mol Sci2025https://conductscience.org/library/papers/41097083PubMed
41045933Updated efficacy and predictive biomarkers of QL1706, a bifunctional PD-1/CTLA-4 dual blocker in advanced solid tumors-A phase 1/1b study.Cell Rep Med2025https://conductscience.org/library/papers/41045933PubMed
40977663Fibroblast growth factor 19-fibroblast growth factor receptor 4 axis: From oncogenesis to targeted-immunotherapy in advanced hepatocellular carcinoma.World J Gastrointest Oncol2025https://conductscience.org/library/papers/40977663PubMed
40286076Protein O-Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals.Molecules2025https://conductscience.org/library/papers/40286076PubMed
39976135Integrative Multi-Omics Approaches Reveal Selectivity Profiles and Molecular Mechanisms of FIIN-2, a Covalent FGFR Inhibitor.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39976135PubMed
39958385Microbial transformations of bile acids and their receptors in the regulation of metabolic dysfunction-associated steatotic liver disease.Liver Res2023https://conductscience.org/library/papers/39958385PubMed
39915447Hepatocellular carcinoma: signaling pathways and therapeutic advances.Signal Transduct Target Ther2025https://conductscience.org/library/papers/39915447PubMed
39875570FGF-based drug discovery: advances and challenges.Nat Rev Drug Discov2025https://conductscience.org/library/papers/39875570PubMed
39682130Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance.Cancers (Basel)2024https://conductscience.org/library/papers/39682130PubMed
39567523A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma.Nat Commun2024https://conductscience.org/library/papers/39567523PubMed
39522105Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway.Apoptosis2025https://conductscience.org/library/papers/39522105PubMed
39220834Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy.World J Gastrointest Pathophysiol2024https://conductscience.org/library/papers/39220834PubMed
39006147Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma.Hepatol Forum2024https://conductscience.org/library/papers/39006147PubMed
38981913Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization.Inflamm Res2024https://conductscience.org/library/papers/38981913PubMed

See all 229 cited byDownload CSV of cited by

Genes43

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CCS9973PubTator's text mininghttps://conductscience.org/library/genes/9973NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
CLIC11192PubTator's text mininghttps://conductscience.org/library/genes/1192NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FGF199965PubTator's text mininghttps://conductscience.org/library/genes/9965NCBI Gene
FGF22247PubTator's text mininghttps://conductscience.org/library/genes/2247NCBI Gene
FGF32248PubTator's text mininghttps://conductscience.org/library/genes/2248NCBI Gene
FGF42249PubTator's text mininghttps://conductscience.org/library/genes/2249NCBI Gene
FGFR42264PubTator's text mininghttps://conductscience.org/library/genes/2264NCBI Gene
FNDC3B64778PubTator's text mininghttps://conductscience.org/library/genes/64778NCBI Gene
HCK3055PubTator's text mininghttps://conductscience.org/library/genes/3055NCBI Gene
HNF4A3172PubTator's text mininghttps://conductscience.org/library/genes/3172NCBI Gene
IRF43662PubTator's text mininghttps://conductscience.org/library/genes/3662NCBI Gene
LTO1220064PubTator's text mininghttps://conductscience.org/library/genes/220064NCBI Gene
MAPK126300PubTator's text mininghttps://conductscience.org/library/genes/6300NCBI Gene
MET4233PubTator's text mininghttps://conductscience.org/library/genes/4233NCBI Gene

See all 43 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21397858

GET https://conductscience.org/api/papers/v1/21397858/references?page=2